Sarah Bowden

People have been suffering for years with long COVID, and patients say that the pace of the NIH's search for new treatments has been too slow. And the $300 million probably isn't enough money to produce a new drug. Megan Stone is the executive director of the Long COVID Campaign.

People have been suffering for years with long COVID, and patients say that the pace of the NIH's search for new treatments has been too slow. And the $300 million probably isn't enough money to produce a new drug. Megan Stone is the executive director of the Long COVID Campaign.

The NIH says it understands the urgency for long COVID treatments. But first, scientists needed a solid understanding of long COVID's biological mechanisms. For NPR News, I'm Sarah Bowden.

The NIH says it understands the urgency for long COVID treatments. But first, scientists needed a solid understanding of long COVID's biological mechanisms. For NPR News, I'm Sarah Bowden.